摘要
Purpose<br/>To investigate whether plasma Epstein-Barr virus (EBV) DNA load at induction chemotherapy (ICT) completion (postICT-DNA) is a useful outcome predictor in locoregionally advanced nasopharyngeal carcinoma (NPC) and to compare the prognostic value of postICT- DNA and post–chemoradiation therapy (CCRT) DNA (postRT-DNA).<br/>Methods and Materials<br/>We retrospectively reviewed 278 patients with stage III-IV NPC treated with ICT followed by concurrent CCRT. The EBV DNA load was measured by quantitative polymerase chain reaction pre-ICT (pre-DNA), at ICT completion (postICT-DNA), and 1?week after CCRT completion (postRT-DNA).<br/>Results<br/>PostICT-DNA was associated with significantly worse 3-year overall survival (86.4% vs. 93.4%, P?=?.023), distant metastasis–free survival (69.2% vs. 93.9%, P?<?.001), and disease-free survival (64.6% vs. 88.7%, P?<?.001) than was undetectable postICT-DNA. In multivariate analysis, postICT-DNA was an independent predictor of overall survival (hazard ratio [HR], 2.567; 95% confidence interval [CI], 1.104-5.967; P?=?.029), distant metastasis–free survival (HR, 5.618; 95% CI, 2.781-11.348; P?<?.001), and disease-free survival (HR, 3.672; 95% CI, 2.064-6.533; P?<?.001). The postICT-DNA and postRT-DNA areas under the curve were 0.584 and 0.561 (P?<?.001), respectively, for predicting 3-year death; 0.717 and 0.649 (P?<?.001), respectively, for predicting 3-year metastasis; and 0.659 and 0.602 (P?<?.001), respectively, for predicting 3-year disease failure.<br/>Conclusions<br/>Plasma EBV DNA load at ICT completion is a powerful and earlier outcome predictor in locoregionally advanced NPC that would facilitate further risk stratification and early treatment modification.
- Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinomaChen, Fo-Ping; Luo, Ying-Shan; Chen, Kai; Li, Jun-Yun; Huo, Lan-Qing; Shi, Liu; Ou-Yang, Yi; Cao, Xin-Ping*European Journal of Cancer, 2021, 151: 63-71.
- The Prognostic Value of Plasma Epstein-Barr Viral DNA and Tumor Response to Neoadjuvant Chemotherapy in Advanced-Stage Nasopharyngeal CarcinomaLiu, Li Ting; Tang, Lin Quan; Chen, Qiu Yan; Zhang, Lu; Guo, Shan Shan; Guo, Ling; Mo, Hao Yuan; Zhao, Chong; Guo, Xiang; Cao, Ka Jia; Qian, Chao Nan; Zeng, Mu Sheng; Bei, Jin Xin; Hong, Ming Huang; Shao, Jian Yong; Sun, Ying; Ma, Jun; Mai, Hai Qiang*International Journal of Radiation Oncology Biology Physics, 2015, 93(4): 862-869.被引 93
- Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinomaLi, Wanxia; Chen, Jing; Liang, Bijun; Li, Zonghua; Li, Junzheng; Yuan, Xiaofei; Wu, Shuting; Zeng, Fangfang; Peng, Xinyu; Li, Yanfei; Lu, Juan*; Zhao, Feipeng*; Liu, Xiong*Cancer Medicine, 2021, 10(3): 883-894.被引 12
